Edwards Lifesciences Corp announced their financial results for Q2 2024 and their agreement to acquire JenaValve Technology, Inc. and Endotronix, Inc. for a total upfront purchase price of approximately $1.2 billion in cash.
AI Assistant
EDWARDS LIFESCIENCES CORP
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.